Trial · NCT00651742
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Tumor Response Rate (ORR) | S-1 30 mg/m^2 | Independent Assessment | 4.0 | 95% Confidence Interval 0.1 to 20.4 | percentage of participants |
| Overall Tumor Response Rate (ORR) | S-1 30 mg/m^2 | Investigator Assessment | 9.5 | 95% Confidence Interval 1.2 to 30.4 | percentage of participants |
| Disease Control Rate (DCR) | S-1 30 mg/m^2 | Independent Assessment | 68.0 | 95% Confidence Interval 46.5 to 85.1 | percentage of participants |
| Disease Control Rate (DCR) | S-1 30 mg/m^2 | Investigator Assessment | 76.2 | 95% Confidence Interval 52.8 to 91.8 | percentage of participants |
| Duration of Response (DR) | S-1 30 mg/m^2 | Independent Assessment | 7.4 | 95% Confidence Interval NA to NA | months |
| Duration of Response (DR) | S-1 30 mg/m^2 | Investigator Assessment | NA | 95% Confidence Interval 2.8 to NA | months |
| Time to Tumor Progression (TTP) | S-1 30 mg/m^2 | Independent Assessment | 3.5 | 95% Confidence Interval 1.6 to 5.5 | months |
| Time to Tumor Progression (TTP) | S-1 30 mg/m^2 | Investigator Assessment | 3.5 | 95% Confidence Interval 2.5 to 5.3 | months |
| Overall Survival (OS) | S-1 30 mg/m^2 | 9.1 | 95% Confidence Interval 4.7 to 11.2 | months | |
| Progression-free Survival (PFS) | S-1 30 mg/m^2 | Independent Assessment | 3.5 | 95% Confidence Interval 1.6 to 5.5 | months |
| Progression-free Survival (PFS) | S-1 30 mg/m^2 | Investigator Assessment | 3.5 | 95% Confidence Interval 2.5 to 5.3 | months |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 100% shift to Final assessment score 100% | 6 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 100% shift to Final assessment score 90% | 7 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 100% shift to Final assessment score 70% | 1 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 100% shift to Final assessment score 0% | 1 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 90% shift to Final assessment score 90% | 1 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 90% shift to Final assessment score 80% | 3 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 90% shift to Final assessment score 70% | 1 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 90% shift to Final assessment score 60% | 1 | Participants | |
| Number of Participants With Karnofsky Performance Status (KPS) Score - Shift From Baseline Score to Final Assessment Score | S-1 30 mg/m^2 | Baseline score 90% shift to Final assessment score 0% | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00651742/results